Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 87.99 USD 0.99% Market Closed
Market Cap: 9.3B USD

Wall Street
Price Targets

CORT Price Targets Summary
Corcept Therapeutics Inc

Wall Street analysts forecast CORT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CORT is 137.93 USD with a low forecast of 122.21 USD and a high forecast of 152.15 USD.

Lowest
Price Target
122.21 USD
39% Upside
Average
Price Target
137.93 USD
57% Upside
Highest
Price Target
152.15 USD
73% Upside
Corcept Therapeutics Inc Competitors:
Price Targets
688321
Shenzhen Chipscreen Biosciences Co Ltd
35% Upside
NAVA
Navamedic ASA
46% Upside
CIPLA
Cipla Ltd
14% Upside
APLLTD
Alembic Pharmaceuticals Ltd
20% Upside
2DT
Amneal Pharmaceuticals Inc
12% Upside
SUNPHARMA
Sun Pharmaceutical Industries Ltd
10% Upside
688176
Jiangsu Yahong Meditech Co Ltd
3% Downside

Revenue
Forecast

Revenue Estimate
Corcept Therapeutics Inc

The compound annual growth rate of Corcept Therapeutics Inc's revenue for the next 4 years is 36%.

N/A
Past Growth
36%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Corcept Therapeutics Inc

The compound annual growth rate of Corcept Therapeutics Inc's operating income for the next 4 years is 69%.

N/A
Past Growth
69%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Corcept Therapeutics Inc

The compound annual growth rate of Corcept Therapeutics Inc's net income for the next 4 years is 58%.

N/A
Past Growth
58%
Estimated Growth
Estimates Accuracy
3%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CORT's stock price target?
Price Target
137.93 USD

According to Wall Street analysts, the average 1-year price target for CORT is 137.93 USD with a low forecast of 122.21 USD and a high forecast of 152.15 USD.

What is Corcept Therapeutics Inc's Revenue forecast?
Projected CAGR
36%

The compound annual growth rate of Corcept Therapeutics Inc's revenue for the next 4 years is 36%.

What is Corcept Therapeutics Inc's Operating Income forecast?
Projected CAGR
69%

The compound annual growth rate of Corcept Therapeutics Inc's operating income for the next 4 years is 69%.

What is Corcept Therapeutics Inc's Net Income forecast?
Projected CAGR
58%

The compound annual growth rate of Corcept Therapeutics Inc's net income for the next 4 years is 58%.

Back to Top